Alex Kotzer
Nessuna posizione attualmente
Profilo
Mr. Alex Kotzer is Chairman & Chief Executive Officer at Regenera Pharma Ltd.
He is on the Board of Directors at Compugen Ltd.
He received his undergraduate degree from the Technion-Israel Institute of Technology.
Precedenti posizioni note di Alex Kotzer
| Società | Posizione | Fine |
|---|---|---|
Regenera Pharma Ltd.
 Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Amministratore Delegato | - |
| COMPUGEN LTD. | Presidente | 03/06/2009 |
Formazione di Alex Kotzer
| Technion-Israel Institute of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |
- Borsa valori
- Insiders
- Alex Kotzer
